CMV-VST clinical trials

CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency

This study looks at a new way to treat serious cytomegalovirus (CMV) infection in young patients with a very weak immune system. It uses special infection-fighting cells from a donor to help the patient's body fight off the virus, especially when other treatments haven't worked.